PMC6307471_01
Abdominal enhanced CT of a 44-year-old male SAP patient (case 1) (a) at 5 days after the first pancreatic duct stenting showing extensive pancreatic necrosis; (b) at 2 weeks after the first pancreatic duct stenting showing aggravated pancreatic necrosis and peripancreatic fluid; (c and d) at 1 week after the second pancreatic duct stenting showing peripancreatic infectious necrosis and the pancreatic duct stent (marked by the black arrow) that has slipped into the duodenum; (e) at 12 days, (f) 17 days, (g) 30 days and (h) 45 days after the second nasopancreatic drainage showing progressively decreased peripancreatic infectious necrosis. The nasopancreatic duct is marked by a black arrow. CT, computed tomography; SAP, severe acute pancreatitis.
etm-17-01-0432-g00.jpg
PMC6307471_01_etm-17-01-0432-g00.jpg
f1-etm-0-0-6958
Computed tomography (CT) scan showed progressive pancreatic necrosis and acute peripancreatic fluid accumulation (Fig. 1a and b). The pancreatic duct stent had slipped into duodenum (Fig. 1c and d). CT scan showed the gradually decreased peripancreatic infection necrosis (Fig. 1e-h).
Images showing the amount and color of pancreatic fluid from a 44-year-old male SAP patient (case 1) (a) during the second nasopancreatic drainage, (b) at 1 day, and (c) at 1 week after the surgery. SAP, severe acute pancreatitis.
etm-17-01-0432-g01.jpg
PMC6307471_01_etm-17-01-0432-g01.jpg
f2-etm-0-0-6958
Dark red purulent pancreatic fluid was removed during the surgery (100 ml, Fig. 2a) and daily postoperatively (50-200 ml, Fig. 2b). The fluid became clear after 1 week (Fig. 2c).
PMC6307471_02
PMC6307471_03